SurModics (SRDX) PT Raised to $74 at Needham & Company
Needham & Company raised its price target on SurModics (NASDAQ: SRDX) to $74.00 (from $55.00) while maintaining a Buy rating.Analyst ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
